eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2013
vol. 38
 
Share:
Share:
abstract:

miR-142-3p inhibits LPS-induced activation of NF-κB by targeting IRAK1 in colorectal cancer

Xu Zhiying
,
Peng Zhou
,
Ping Zhen Zhou
,
Jie Zhang
,
Le bo Cao
,
Xia Cui Liu
,
Jie Li

(Centr Eur J Immunol 2013; 38 (4): 416-420)
Online publish date: 2013/12/30
View full text Get citation
 
PlumX metrics:
Inflammatory signals originating from colorectal cancer cells have a vital role in the development of colorectal cancer (CRC). microRNAs (miRNAs) have been demonstrated to be involved in the development and progression of CRC. miRNA-142-3p (miR-142-3p) has been reported to be a modulator of inflammatory signals. It has also been shown that miR-142-3p is downregulated in CRC and it acts to be a tumor suppressor. In the present study, interleukin-1 receptor-associated kinase 1 (IRAK1), a key mediator of NF-κB pathway, was identified as a direct target of miR-142-3p. It was also found that miR-142-3p repressed the activation of NF-κB signal induced by LPS in colorectal cancer cells, therefore reducing the expression of inflammatory cytokines, such as IL-6, IL-8, MCP-1, CCL5 and CSF-1. Thus, it is believed that miR-142-3p is a key component in the regulation of NF-κB activity and its anti-inflammatory role may contribute to its suppression of carcinogenesis of CRC.
keywords:

colorectal cancer, non-coding RNA, inflammatory factors

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.